[120] developed Diketopyrrolopyrrole-based CDs which are highly photostable and capable of strong cellular uptake and tumour suppression at low concentrations [120]
Last reviewed: June 11, 2026 Last updated: June 11, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
BPC-157: The Injury Recovery Breakthrough If there's one peptide that has captured the attention of athletes, coaches, and injury specialists in 2026, it's BPC-157
Weight loss doesnt have to feel like a constant tug-of-war between motivation and exhaustion
Most people experience meaningful weight loss even while managing digestive changes, and symptoms typically resolve while fat loss continues over the following weeks
This protocol focuses on cellular signaling and tissue balance to help support mobility, flexibility, and everyday movement